Donepezil Impurity 6
|
|
844694-85-5
|
Edaravone impurity A
|
依達(dá)拉奉雜質(zhì)A
|
7477-67-0
|
Donepezil Impurity 7
|
|
4803-57-0
|
Doxepin EP Impurity B
|
多塞平EP雜質(zhì)B
|
4504-88-5
|
Deubutafrazine Impurity
|
艾司奧美拉唑雜質(zhì)H215/01
|
1803449-15-1
|
Ezetimibe (RRR)-Isomer
|
依折麥布(RRR)異構(gòu)體
|
1593542-96-1
|
Edoxaban Impurity 2
|
依度沙班雜質(zhì)2
|
720720-96-7
|
Doxepin EP Impurity A
|
6,11-二氫二苯并[b,e]氧雜卓-11-酮
|
4504-87-4
|
Edoxaban iMpurities 13
|
依度沙班雜質(zhì)13
|
767625-11-6
|
Ezetimibe (SSS)-Isomer
|
依折麥布(SSS)異構(gòu)體
|
1593543-07-7
|
Ezetimibe (RSR)-Isomer
|
依折麥布(RSR)異構(gòu)體
|
1376614-99-1
|
Ezetimibe (SSR)-Isomer
|
依折麥布(SSR)異構(gòu)體
|
823189-96-5
|
Donepezil Impurity 9
|
|
120012-04-6
|
Donepezil Impurity 8
|
|
120013-45-8
|
Doxepin EP Impurity C
|
多塞平EP雜質(zhì)C
|
4504-96-5
|
Erlotinib Impurity 11
|
厄洛替尼雜質(zhì)16
|
236750-65-5
|
Erlotinib Hydrochloride iMpurity 10
|
厄洛替尼雜質(zhì)10
|
183319-69-9
|
Noradrenaline Impurity 16
|
依折麥布(RRS)異構(gòu)體
|
163380-16-3
|
Enzalutamide impurity A
|
恩雜魯胺雜質(zhì)A
|
112704-79-7
|
Enzalutamide impurity B
|
恩雜魯胺雜質(zhì)B
|
749927-69-3
|
Enzalutamide
|
恩雜魯胺
|
915087-33-1
|
Valsartan Methyl Ester
|
依折麥布雜質(zhì)C
|
1296129-15-1
|
Ezetimibe Impurity A
|
依折麥布雜質(zhì)A
|
191330-56-0
|
Edoxaban Impurity 17
|
依度沙班雜質(zhì)17
|
1255529-24-8
|
Edoxaban Impurity 15
|
依度沙班雜質(zhì)15
|
1255529-25-9
|
Edoxaban Impurity 16
|
依度沙班雜質(zhì)16
|
500572-10-1
|
Edoxaban EP impurity H
|
依度沙班EP雜質(zhì)H
|
1255529-28-2
|
Edoxaban EP Impurity 18
|
依度沙班EP雜質(zhì)C
|
1255529-27-1
|
Edoxaban EP impurity G
|
依度沙班EP雜質(zhì)G
|
1255529-26-0
|
Edoxaban Impurity 20
|
依度沙班雜質(zhì)20
|
929693-30-1
|
Edoxaban Impurity 21
|
依度沙班雜質(zhì)21
|
929693-31-2
|
Edoxaban Impurity 19
|
依度沙班雜質(zhì)19
|
834919-19-6
|
Edaravone impurity B
|
依達(dá)拉奉雜質(zhì)B
|
68195-63-1
|
Edaravone Impurity 4
|
依達(dá)拉奉雜質(zhì)4
|
1016-41-7
|
2-(3-methyl-5-oxo-1-phenyl
|
依達(dá)拉奉雜質(zhì)P1對照品
|
1357477-99-6
|
Edaravone Impurity 1
|
依達(dá)拉奉雜質(zhì)1
|
177415-76-8
|
Edaravone Impurity 3
|
依達(dá)拉奉雜質(zhì)3
|
300543-31-1
|
Edaravone Impurity 2
|
依達(dá)拉奉雜質(zhì)2對照品
|
124009-63-8
|
Edaravone impurity P3
|
依達(dá)拉奉雜質(zhì)P3
|
1323485-71-7
|
Enzalutamide impurity C
|
恩雜魯胺雜質(zhì)C
|
179232-29-2
|
Erlotinib Impurity 25
|
厄洛替尼雜質(zhì)25
|
179688-26-7
|
Ezetimibe Impurity E
|
依折麥布雜質(zhì)E
|
302781-98-2
|
Duloxetine impurity 15
|
度洛西汀雜質(zhì)15
|
5424-47-5
|
Erlotinib Impurity 1
|
厄洛替尼雜質(zhì)1
|
183322-21-6
|
Esomeprazole Impurity E01
|
埃索美拉唑雜質(zhì)E1
|
142885-92-5
|
Esomeprazole Impurity B04
|
艾司奧美拉唑雜質(zhì)B04
|
73590-93-9
|
Esomeprazole Impurity B05
|
埃索美拉唑雜質(zhì)B05
|
704910-89-4
|
Esomeprazole Impurity H215 substance
|
埃索美拉唑雜質(zhì)H215前體
|
103876-98-8
|
Esomeprazole Impurity H215/02
|
艾司奧美拉唑雜質(zhì)H215/02
|
1803449-02-6
|
DL-Methionine Sulfoxide
|
艾司奧美拉唑雜質(zhì)H431
|
1227380-90-6
|
Ezetimibe Impurity G
|
依折麥布雜質(zhì)G
|
1700622-06-5
|
2-hydroxy-55-(methylthio)butanamide
|
依折麥布雜質(zhì)F
|
190595-66-5
|
2-hydroxy-17-(methylthio)butanamide
|
埃索美拉唑雜質(zhì)A
|
37052-78-1
|
Ezetimibe Impurity D
|
依折麥布雜質(zhì)D
|
204589-58-2
|
DL-Methionine Sulfoxide
|
依折麥布雜質(zhì)
|
1197811-72-5
|
Edaravone Impurity 5
|
依達(dá)拉奉雜質(zhì)5
|
29214-62-8
|
Doxepin EP Impurity D
|
多塞平EP雜質(zhì)D
|
25127-31-5
|
Lactate tetramer
|
奧美拉唑雜質(zhì)F
|
125656-82-8
|
Deubutafrazine Impurity
|
埃索美拉唑雜質(zhì)E
|
176219-04-8
|
Omeprazole Impurity B
|
埃索美拉唑雜質(zhì)B
|
110374-16-8
|
Esomeprazole Impurity J
|
奧美拉唑雜質(zhì)H
|
863029-89-4
|
Nintedanib Impurity 51
|
埃索美拉唑雜質(zhì)D
|
88546-55-8
|
Esomeprazole Impurity G
|
埃索美拉唑雜質(zhì)G
|
73590-58-6
|
Omeprazole Impurity H193
|
埃索美拉唑雜質(zhì)H193
|
784143-42-6
|
Esomeprazole Impurity H
|
埃索美拉唑雜質(zhì)H
|
317807-10-6
|
1,3-dimethyl-40-nitrosourea
|
埃索美拉唑雜質(zhì)20
|
86604-78-6
|
Esomeprazole Impurity K
|
埃索美拉唑雜質(zhì)K
|
1346599-85-6
|
(S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine
|
度洛西汀雜質(zhì)8
|
132335-46-7
|
(S)-phenyl methyl(3-(naphthalen-1-yloxy)
|
度洛西汀雜質(zhì)10
|
947686-09-1
|
3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol
|
度洛西汀雜質(zhì)16
|
13636-02-7
|
(S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol
|
度洛西汀雜質(zhì)17
|
132335-44-5
|
Duloxetine impurity 13
|
度洛西汀雜質(zhì)13
|
199191-67-8
|
Duloxetine impurity 12
|
度洛西汀雜質(zhì)12
|
199191-66-7
|
Duloxetine IMpurity E
|
度洛西汀EP雜質(zhì)E
|
1033803-59-6
|
(R)-Amlodipine
|
度洛西汀EP雜質(zhì)C
|
949095-98-1
|
Ezetimibe (SRR)-Isomer
|
依折麥布(SRR)異構(gòu)體
|
1478664-02-6
|
Linagliptin Impurity CD10099
|
A埃索美拉唑雜質(zhì)I
|
158812-85-2
|
Erlotinib Impurity 27
|
厄洛替尼雜質(zhì)27
|
183322-18-1
|
Erlotinib Impurity 5
|
厄洛替尼雜質(zhì)5
|
183320-15-2
|
Erlotinib Impurity 9
|
厄洛替尼雜質(zhì)9
|
183321-86-0
|
Erlotinib Impurity 19
|
厄洛替尼雜質(zhì)19
|
1312937-41-9
|
Tofacitinib Impurity FD+DX
|
厄洛替尼雜質(zhì)29
|
54060-30-9
|
Erlotinib Impurity 28
|
厄洛替尼雜質(zhì)28
|
183322-20-5
|
Erlotinib Impurity 12
|
厄洛替尼雜質(zhì)17
|
236750-62-2
|
Erlotinib Impurity 24
|
厄洛替尼雜質(zhì)24
|
183322-17-0
|
Erlotinib Impurity 13
|
厄洛替尼雜質(zhì)13
|
179688-29-0
|
Edoxaban Impurity 1
|
依度沙班雜質(zhì)1
|
1210348-34-7
|
Enzalutamide impurity O
|
恩雜魯胺雜質(zhì)J
|
1242137-16-1
|
Erlotinib Impurity 4
|
厄洛替尼雜質(zhì)4
|
1145671-52-8
|
Erlotinib Impurity 2
|
厄洛替尼雜質(zhì)2
|
183320-04-9
|
Erlotinib Impurity 23
|
厄洛替尼雜質(zhì)23
|
950596-58-4
|
1,3-dimethyl-12-nitrosourea
|
厄洛替尼雜質(zhì)C
|
86604-75-4
|
Erlotinib Impurity 6
|
厄洛替尼雜質(zhì)6
|
183320-12-9
|
Erlotinib Impurity 8
|
厄洛替尼雜質(zhì)8
|
1346601-52-2
|
Erlotinib Impurity 7
|
厄洛替尼雜質(zhì)7
|
1624294-38-7
|
Cilnidipine Impurity 34
|
埃索美拉唑雜質(zhì)C
|
73590-85-9
|
Edoxaban iMpurities 6
|
依度沙班雜質(zhì)6
|
480452-37-7
|
Edoxaban iMpurities 9
|
依度沙班雜質(zhì)9
|
1255529-23-7
|
Rosuvastatin EP Impurity A
|
A依度沙班雜質(zhì)3
|
1243308-37-3
|
Edoxaban iMpurities 4
|
依度沙班雜質(zhì)4
|
480452-36-6
|